The Australian Academy of Science's National Committee for Chemistry has developed a strategic vision for Australian chemistry for the next decade. [ + ]

The Grattan Institute has released a report calling for the government to change the way it pays for pathology testing, in a move which would save up to $175 million a year. [ + ]

Prescient Therapeutics has marked two key milestones — the dosing of the last patient in the escalation stage of its Phase Ib breast cancer trial and the appointment of a new CEO. [ + ]

Regenerative medicine company Avita Medical has appointed MSM Medical as its newest European distributor and sold its respiratory business to Medical Developments International. [ + ]

Stem cell company Cynata Therapeutics has received an R&D Tax Incentive refund of $932,580.65 for the 2014–15 financial year. [ + ]

Sophia Genetics and Integrated DNA Technologies are helping hospitals address their need to adopt next-generation sequencing (NGS) tests for routine clinical diagnostics. [ + ]

An American-Australian research team has identified what may be the initial target of the immune response that causes type 1 diabetes. [ + ]

Particle & Surface Sciences has been appointed the exclusive distributor for Surface Measurement Systems in Australia and New Zealand. [ + ]

Australian and British scientists are collaborating on the creation of a single miniature biodegradable device that can not only track a disease, but can also treat it. [ + ]

Netherlands-based company QIAGEN will collaborate with California's 10x Genomics on the development and promotion of next-generation sequencing (NGS), single-cell biology and bioinformatics solutions. [ + ]

A new ASTM standard will enable manufacturers and regulators to determine whether the most sustainable chemicals are being used for consumer products, thus encouraging the use of such chemicals. [ + ]

Japanese researchers have developed a harmless and non-invasive method of measuring blood glucose using far-infrared light. [ + ]

AIB Labs has opened applications to its Research Infrastructure Fund — a grant program designed to facilitate the establishment and running of research service facilities to serve the needs of the South Australian bioscience research community. [ + ]

With the support of the Medical Device Partnering Program, Fluoro Medical will this year launch a foldable splint that can fit into a first aid kit. [ + ]

Researchers have discovered that supposed 'junk' DNA — that is, DNA which does not contain genes that code for proteins — plays a role in suppressing breast cancer. [ + ]